BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.84M | -448.00K | 12.46M | -1.70M | -- |
| Total Depreciation and Amortization | 1.38M | 1.38M | -1.47M | 2.32M | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.74M | 4.55M | -10.21M | 5.41M | -- |
| Change in Net Operating Assets | 85.00K | -3.76M | 857.00K | -1.22M | -- |
| Cash from Operations | 7.37M | 1.73M | 1.65M | 4.80M | 6.46M |
| Capital Expenditure | -1.91M | -425.00K | -802.00K | -1.55M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.63M | -26.75M | 74.44M | -133.00K | -- |
| Cash from Investing | -39.53M | -27.18M | 73.64M | -1.68M | -13.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50M | -2.50M | -3.43M | -2.71M | -- |
| Issuance of Common Stock | 18.00K | -- | 65.00K | 46.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -396.00K | -492.00K | -725.00K | 1.63M | -- |
| Cash from Financing | -2.88M | -2.99M | -4.09M | -1.04M | -704.00K |
| Foreign Exchange rate Adjustments | -- | -- | 29.00K | 36.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.04M | -28.44M | 71.23M | 2.12M | -7.68M |